Medpace Holdings, Inc. logo
Medpace Holdings, Inc. (MEDP)
Compare

Medpace Holdings, Inc. (MEDP) PB Ratio: 22.13

Is Medpace Holdings, Inc.’s P/B ratio high or low?

Medpace Holdings, Inc.'s P/B ratio of 22.13 is in line with its 5-year average of 22.04, near the low end of its 5-year range (5.50–95.69).

55.91% below its 12-month average of 50.19.

MEDP PB Ratio Chart

MEDP PB Ratio
22.13+41.32% 1Y
Zoom

MEDP Average PB Ratio Chart

MEDP Current vs Average PB Ratio Chart

MEDP PB Ratio Metrics

PB RATIO

22.13

PB RATIO AVG TTM

50.19

PB RATIO AVG 3Y

18.60

PB RATIO AVG 5Y

15.87

PB RATIO AVG 10Y

9.64

PB RATIO AVG 15Y

N/A

PB RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-55.91%

CURRENT VS 3Y AVG

+18.95%

CURRENT VS 5Y AVG

+39.43%

CURRENT VS 10Y AVG

+129.66%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

MEDP Competitors' PB Ratio

NAMEMARKET CAPPB RATIOTTM3Y5Y
Medpace Holdings, Inc. (MEDP)$13.05B22.1350.1918.6015.87
Solventum Corporation (SOLV)vs ›$12.91B2.633.033.373.37
The Cooper Companies, Inc. (COO)vs ›$12.69B1.541.742.162.34
DaVita Inc. (DVA)vs ›$13.46BN/A42.8621.6816.81
Align Technology, Inc. (ALGN)vs ›$12.43B2.992.974.386.27
Revvity, Inc. (RVTY)vs ›$10.91B1.521.501.652.13
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B1.441.000.991.29
Baxter International Inc. (BAX)vs ›$10.19B1.741.592.243.03
Hologic, Inc. (HOLX)vs ›$16.97B3.273.173.483.78
Charles River Laboratories International, Inc. (CRL)vs ›$8.78B3.042.642.834.00

P/B vs. its own history

At 22.13, P/B is richer than usual, sitting higher than 90% of its 10-year history.

10-year low

1.48

median

7.38

10-year high

95.69

cheaperricher

Book Value Analysis

P/B Ratio

22.13

Market Price / Book Value per Share

Medpace Holdings, Inc. PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medpace Holdings, Inc. PB Ratio FAQ

What is the P/B ratio for Medpace Holdings, Inc. (MEDP)?
The P/B ratio for MEDP stock is 22.13.
Is Medpace Holdings, Inc.'s P/B ratio high or low?
Medpace Holdings, Inc.'s P/B ratio of 22.13 is in line with its 5-year average of 22.04, near the low end of its 5-year range (5.50–95.69).
What is the TTM average P/B ratio for Medpace Holdings, Inc. (MEDP)?
The TTM average P/B ratio for MEDP stock is 50.19.
What is the 3Y average P/B ratio for Medpace Holdings, Inc. (MEDP)?
The 3Y average P/B ratio for MEDP stock is 18.60.
What is the 5Y average P/B ratio for Medpace Holdings, Inc. (MEDP)?
The 5Y average P/B ratio for MEDP stock is 15.87.
What is the 10Y average P/B ratio for Medpace Holdings, Inc. (MEDP)?
The 10Y average P/B ratio for MEDP stock is 9.64.

Medpace Holdings, Inc. PB Ratio History

DATEPB RATIO
2026-06-1722.13
2026-06-1622.34
2026-06-1522.63
2026-06-1222.62
2026-06-1123.00
2026-06-1022.54
2026-06-0922.60
2026-06-0822.17
2026-06-0521.99
2026-06-0422.20
2026-06-0321.82
2026-06-0221.57
2026-06-0121.85
2026-05-2921.64
2026-05-2821.69
2026-05-2720.72
2026-05-2620.77
2026-05-2220.95
2026-05-2120.82
2026-05-2020.42
2026-05-1920.33
2026-05-1820.36
2026-05-1520.10
2026-05-1420.29
2026-05-1320.51
2026-05-1220.32
2026-05-1120.20
2026-05-0820.52
2026-05-0720.75
2026-05-0620.66
2026-05-0520.83
2026-05-0420.19
2026-05-0120.21
2026-04-3020.27
2026-04-2920.02
2026-04-2819.83
2026-04-2720.40
2026-04-2419.87
2026-04-2319.04
2026-04-2232.08
2026-04-2132.49
2026-04-2033.34
2026-04-1732.85
2026-04-1632.53
2026-04-1532.72
2026-04-1432.81
2026-04-1331.62
2026-04-1031.14
2026-04-0931.64
2026-04-0832.85
2026-04-0732.08
2026-04-0631.29
2026-04-0231.44
2026-04-0130.88
2026-03-3130.30
2026-03-3029.04
2026-03-2728.47
2026-03-2629.44
2026-03-2529.45
2026-03-2429.07
2026-03-2328.83
2026-03-2028.55
2026-03-1929.08
2026-03-1828.69
2026-03-1728.72
2026-03-1628.62
2026-03-1328.42
2026-03-1228.00
2026-03-1130.14
2026-03-1029.45
2026-03-0930.19
2026-03-0629.69
2026-03-0529.61
2026-03-0429.39
2026-03-0329.36
2026-03-0228.86
2026-02-2728.50
2026-02-2628.21
2026-02-2527.64
2026-02-2427.90
2026-02-2328.07
2026-02-2028.63
2026-02-1928.17
2026-02-1828.15
2026-02-1727.02
2026-02-1327.01
2026-02-1226.25
2026-02-1126.75
2026-02-1028.14
2026-02-0953.66
2026-02-0654.84
2026-02-0554.76
2026-02-0456.81
2026-02-0357.52
2026-02-0259.51
2026-01-3058.93
2026-01-2960.01
2026-01-2860.50
2026-01-2760.93
2026-01-2660.92
2026-01-2359.50
2026-01-2261.34
2026-01-2162.79
2026-01-2060.95
2026-01-1661.81
2026-01-1562.53
2026-01-1462.37
2026-01-1361.56
2026-01-1260.63
2026-01-0960.20
2026-01-0860.71
2026-01-0762.03
2026-01-0661.61
2026-01-0559.37
2026-01-0257.77
2025-12-3156.83
2025-12-3057.56
2025-12-2957.67
2025-12-2657.42
2025-12-2457.86
2025-12-2357.64
2025-12-2257.83
2025-12-1957.51
2025-12-1856.68
2025-12-1756.36
2025-12-1656.53
2025-12-1556.57
2025-12-1256.45
2025-12-1157.28
2025-12-1056.74
2025-12-0955.05
2025-12-0855.56
2025-12-0555.46
2025-12-0455.12
2025-12-0358.33
2025-12-0259.06
2025-12-0159.49
2025-11-2859.94
2025-11-2661.37
2025-11-2561.90
2025-11-2462.58
2025-11-2159.88
2025-11-2059.31
2025-11-1959.92
2025-11-1859.71
2025-11-1759.27
2025-11-1459.70
2025-11-1359.83
2025-11-1260.46
2025-11-1160.99
2025-11-1060.75
2025-11-0759.61
2025-11-0659.92
2025-11-0560.59
2025-11-0460.15
2025-11-0360.10
2025-10-3159.18
2025-10-3058.72
2025-10-2959.15
2025-10-2858.74
2025-10-2760.35
2025-10-2461.23
2025-10-2360.36
2025-10-2295.69
2025-10-2195.50
2025-10-2095.28
2025-10-1792.42
2025-10-1691.22
2025-10-1590.02
2025-10-1490.47
2025-10-1392.31
2025-10-1087.72
2025-10-0990.78
2025-10-0892.94
2025-10-0793.08
2025-10-0692.81
2025-10-0393.20
2025-10-0293.84
2025-10-0195.19
2025-09-3089.99
2025-09-2987.64
2025-09-2686.95
2025-09-2585.40
2025-09-2487.04
2025-09-2386.83
2025-09-2287.18
2025-09-1987.27
2025-09-1887.85
2025-09-1787.13
2025-09-1685.89
2025-09-1586.88
2025-09-1285.87
2025-09-1187.09
2025-09-1083.43
2025-09-0984.99
2025-09-0886.13
2025-09-0585.23
2025-09-0484.42
2025-09-0384.23
2025-09-0282.84
2025-08-2983.22
2025-08-2882.77
2025-08-2782.87
2025-08-2682.14
2025-08-2581.70
2025-08-2281.15
2025-08-2179.34
2025-08-2081.51
2025-08-1980.88
2025-08-1881.02
2025-08-1580.13
2025-08-1480.28
2025-08-1381.91
2025-08-1280.39
2025-08-1178.72
2025-08-0876.02
2025-08-0775.05
2025-08-0675.32
2025-08-0576.36
2025-08-0475.68
2025-08-0174.05
2025-07-3174.77
2025-07-3076.62
2025-07-2978.40
2025-07-2879.29
2025-07-2578.32
2025-07-2479.75
2025-07-2376.56
2025-07-2283.61
2025-07-2116.23
2025-07-1816.39
2025-07-1716.77
2025-07-1616.55
2025-07-1516.43
2025-07-1416.84
2025-07-1117.00
2025-07-1017.25
2025-07-0916.87
2025-07-0816.95
2025-07-0716.76
2025-07-0316.90
2025-07-0217.13
2025-07-0116.87
2025-06-3016.49
2025-06-2716.33
2025-06-2616.12
2025-06-2516.35
2025-06-2416.57
2025-06-2316.22
2025-06-2016.26
2025-06-1815.91
2025-06-1715.66
2025-06-1615.82
2025-06-1315.67
2025-06-1215.98
2025-06-1115.89
2025-06-1016.08
2025-06-0915.68
2025-06-0615.58
2025-06-0515.43

Showing the most recent 260 of 2,476 data points. The chart above shows the full history.

About Medpace Holdings, Inc.

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Cincinnati, OH
5,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
August James Troendle